Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220380 (US9290488, ZA01) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 0.220 | -55.1 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220382 (US9290488, ZA03) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 0.340 | -54.0 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220363 (US9290488, B20a(i)) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 0.890 | -51.7 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220366 (US9290488, B34a) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.03 | -51.3 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220379 (US9290488, L29b) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.32 | -50.7 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220375 (US9290488, K2b(ii)) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.46 | -50.4 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220384 (US9290488, ZA05) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.97 | -49.7 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220383 (US9290488, ZA04) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.98 | -49.7 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220385 (US9290488, ZA06) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 1.98 | -49.7 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220362 (US9290488, B12a) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.21 | -49.4 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220376 (US9290488, K29b) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 2.64 | -49.0 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220377 (US9290488, L2b(i)) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 3.07 | -48.6 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220381 (US9290488, ZA02) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 3.14 | -48.5 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220386 (US9290488, ZA07) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 3.56 | -48.2 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220378 (US9290488, L2b(ii)) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 3.78 | -48.1 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220373 (US9290488, E54a) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 5.46 | -47.2 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM220384 (US9290488, ZA05) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 7.40 | -46.4 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand dose displacement assays used 0.4-0.8 nM [3H]-U69,593 (NEN; 40 Ci/mmole) with 10-20 μg membrane protein (recombinant kappa opioid rece... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220364 (US9290488, B20a(ii)) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 7.44 | -46.4 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220365 (US9290488, B21a) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 8.22 | -46.1 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220360 (US9290488, B11a(i)) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 9.80 | -45.7 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220374 (US9290488, H3a) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 9.93 | -45.7 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM220383 (US9290488, ZA04) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 11.6 | -45.3 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand dose displacement assays used 0.4-0.8 nM [3H]-U69,593 (NEN; 40 Ci/mmole) with 10-20 μg membrane protein (recombinant kappa opioid rece... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220388 (US9290488, ZA09) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 11.9 | -45.2 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220387 (US9290488, ZA08) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 11.9 | -45.2 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220361 (US9290488, B11a(ii)) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 12.1 | -45.2 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220392 (US9290488, CC02) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 15 | -44.7 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220357 (US9290488, A11a(ii)) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 19.2 | -44.0 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220389 (US9290488, ZA10) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 23 | -43.6 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220372 (US9290488, E53a(ii)) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 23.6 | -43.5 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220359 (US9290488, B2a(ii)) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 27.1 | -43.2 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM220362 (US9290488, B12a) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 29.1 | -43.0 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays were conducted using freshly thawed membranes expressing human μ-receptors (Perkin Elmer, Shelton, Conn.). Radioligand ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM220391 (US9290488, CC01) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 38 | -42.4 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand dose displacement assays used 0.4-0.8 nM [3H]-U69,593 (NEN; 40 Ci/mmole) with 10-20 μg membrane protein (recombinant kappa opioid rece... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM220363 (US9290488, B20a(i)) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 38.9 | -42.3 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays were conducted using freshly thawed membranes expressing human μ-receptors (Perkin Elmer, Shelton, Conn.). Radioligand ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220390 (US9290488, ZA11) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 39.9 | -42.2 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM220361 (US9290488, B11a(ii)) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 40.8 | -42.2 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand dose displacement assays used 0.4-0.8 nM [3H]-U69,593 (NEN; 40 Ci/mmole) with 10-20 μg membrane protein (recombinant kappa opioid rece... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220356 (US9290488, A11a(i)) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 43 | -42.0 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM220366 (US9290488, B34a) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 43.4 | -42.0 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays were conducted using freshly thawed membranes expressing human μ-receptors (Perkin Elmer, Shelton, Conn.). Radioligand ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM220361 (US9290488, B11a(ii)) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 48.9 | -41.7 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays were conducted using freshly thawed membranes expressing human μ-receptors (Perkin Elmer, Shelton, Conn.). Radioligand ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM220392 (US9290488, CC02) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 51 | -41.6 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand dose displacement assays used 0.4-0.8 nM [3H]-U69,593 (NEN; 40 Ci/mmole) with 10-20 μg membrane protein (recombinant kappa opioid rece... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM220365 (US9290488, B21a) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 54.1 | -41.5 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays were conducted using freshly thawed membranes expressing human μ-receptors (Perkin Elmer, Shelton, Conn.). Radioligand ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220368 (US9290488, C20a(ii)) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 55.5 | -41.4 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM220384 (US9290488, ZA05) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 57 | -41.3 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays were conducted using freshly thawed membranes expressing human μ-receptors (Perkin Elmer, Shelton, Conn.). Radioligand ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM220366 (US9290488, B34a) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 72.3 | -40.8 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand dose displacement assays used 0.4-0.8 nM [3H]-U69,593 (NEN; 40 Ci/mmole) with 10-20 μg membrane protein (recombinant kappa opioid rece... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220371 (US9290488, E53a(i)) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 80 | -40.5 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM220383 (US9290488, ZA04) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 83 | -40.4 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays were conducted using freshly thawed membranes expressing human μ-receptors (Perkin Elmer, Shelton, Conn.). Radioligand ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM220392 (US9290488, CC02) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 86 | -40.3 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays were conducted using freshly thawed membranes expressing human μ-receptors (Perkin Elmer, Shelton, Conn.). Radioligand ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM220378 (US9290488, L2b(ii)) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 86 | -40.3 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand dose displacement assays used 0.4-0.8 nM [3H]-U69,593 (NEN; 40 Ci/mmole) with 10-20 μg membrane protein (recombinant kappa opioid rece... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220358 (US9290488, B2a(i)) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 93.5 | -40.1 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220391 (US9290488, CC01) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 98 | -40.0 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM220365 (US9290488, B21a) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 111 | -39.7 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand dose displacement assays used 0.4-0.8 nM [3H]-U69,593 (NEN; 40 Ci/mmole) with 10-20 μg membrane protein (recombinant kappa opioid rece... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 165 total ) | Next | Last >> |